Strategies for the prevention of osteoporosis in postmenopausal women with hormone therapy and serms: Cost-effectiveness issues

被引：0
|
作者：
Torgerson, D
机构：
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [11] The Cost-effectiveness of Hormone Therapy in Younger and Older Postmenopausal Women
    Salpeter, Shelley R.
    Buckley, Nicholas S.
    Liu, Hau
    Salpeter, Edwin E.
    AMERICAN JOURNAL OF MEDICINE, 2009, 122 (01): : 42 - U3
  • [12] The cost-effectiveness of calcium and vitamin D or hormone replacement therapy in the prevention of osteoporosis and osteoporotic fractures in Canadian postmenopausal women.
    Papadimitropoulos, EA
    Goeree, R
    Blackhouse, G
    Coyte, P
    Josse, RG
    Adachi, J
    Greenwood, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S384 - S384
  • [13] Cost-effectiveness of long-term hormone replacement therapy (estrogen plus progestin) in healthy postmenopausal women for osteoporosis prevention
    Yu, YF
    Hay, JW
    Yu, AP
    VALUE IN HEALTH, 2004, 7 (03) : 296 - 297
  • [14] COST-EFFECTIVENESS ANALYSES OF SCREENING AND TREATMENT STRATEGIES FOR POSTMENOPAUSAL OSTEOPOROSIS IN CHINESE WOMEN
    Si, L.
    Winzenberg, T. M.
    Wang, L.
    Palmer, A. J.
    VALUE IN HEALTH, 2014, 17 (07) : A773 - A773
  • [15] Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis
    Andrew J. Rosner
    Daniel T. Grima
    George W. Torrance
    Cathy Bradley
    Jonathan D. Adachi
    Rolf J. Sebaldt
    Donald J. Willison
    PharmacoEconomics, 1998, 14 : 559 - 573
  • [16] Cost effectiveness of multi-therapy treatment strategies in the prevention of vertebral fractures in postmenopausal women with osteoporosis
    Rosner, AJ
    Grima, DT
    Torrance, GW
    Bradley, C
    Adachi, JD
    Sebaldt, RJ
    Willison, DJ
    PHARMACOECONOMICS, 1998, 14 (05) : 559 - 573
  • [17] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hiligsmann, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S50 - S51
  • [18] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hansson-Hedblom, A.
    Geale, K.
    Borgstrom, F.
    Johansson, H.
    Fitzpatrick, L.
    Kanis, J. A.
    VALUE IN HEALTH, 2018, 21 : S197 - S197
  • [19] IDENTIFYING OPTIMAL SCREENING STRATEGIES FOR OSTEOPOROSIS IN POSTMENOPAUSAL CHINESE WOMEN: A COST-EFFECTIVENESS STUDY
    Si, L.
    Winzenberg, T.
    Jiang, Q.
    Palmer, A.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : 627 - 627
  • [20] Cost-effectiveness analysis of raloxifene and hormone replacement therapy in postmenopausal women.
    Chen, TM
    Armstrong, K
    Albert, D
    Hrung, J
    Schwartz, JS
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S45 - S45
12345